Genesis Regenerative Challenges Clinicians to Ask 'What’s In Your Vial?' & Empowers Patients to Become Smarter Consumers

Applied Science For Regeneration… Service Above Self… Excellence In All We Do.

The “What’s in your vial?” series also invites clinicians to a nationwide educational Zoom discussion, “Merging Two Worlds: Product Creation & Testing Meets Clinical Decision-Making,” on November 18, 2026, at 8 p.m. EST

Two coordinated educational campaigns put product transparency, independent testing & better questions at the center of regenerative medicine conversations.

CLEARWATER, FL, UNITED STATES, November 5, 2026 /EINPresswire.com/ -- Genesis Regenerative is challenging the regenerative medicine community to look beyond product labels and attention-grabbing numbers. Its physician-facing “What’s In Your Vial?” series and patient-facing “How To Be A Smart Regenerative Medicine Consumer” series share a central message: informed decisions start with meaningful questions and verifiable information.

Beyond the Label: What Clinicians Should Examine
The physician series asks clinicians to examine what is actually in a product, who tested it, and what the results demonstrate. Topics include laboratory establishment registration, donor screening, independent product testing, tissue origin, and documentation supporting product identity and composition. FDA establishment registration should not be confused with FDA approval or clearance of an individual product.

Rather than relying on claims of “billions” or “trillions,” the campaign highlights the importance of identifying specific proteins and their measured concentrations. Genesis points to independent proteomic testing of its Regenerative Protein Array^® (RPA^®), reporting measured proteins in picograms per milliliter (pg/mL). A numerical count alone does not establish product composition, potency, safety, or clinical effectiveness.

Transparency Is the Standard We Want to Advance
Genesis believes clinicians should be able to review relevant documentation and ask who performed the testing, which methods were used, and what the findings actually mean. This information can support product evaluation and informed patient discussions; it should not be represented as proof of clinical outcomes or as a substitute for a clinician’s independent judgment.

Helping Patients Ask Smarter Questions
The companion patient series introduces terms such as stem cells, exosomes, cell factors and peptides, then encourages patients to ask what those terms mean for the product being discussed. It also explores the limitations of autologous approaches, including platelet-rich plasma (PRP), and why age, individual biology and product source matter. These are educational distinctions, not a claim that one category is universally superior.

The series also asks patients to look beyond large headline numbers: What exactly is being counted? Which molecules have been identified? Who independently verified the information? Patients are encouraged to discuss product source, composition and available evidence with a qualified clinician rather than drawing conclusions from marketing language alone.

Questions Worth Asking Before Choosing a Product
Patients and clinicians can ask: Where does the material originate? Is the relevant laboratory registered with the FDA, and what does that registration mean? What donor-screening and safety-testing documentation is available? Is there independent testing of the finished product? Are specific proteins and concentrations reported? Can the supplier explain lot identification, handling and expiration information? The appropriate documents and tests vary by product and regulatory category; no single checklist establishes that a product is safe, effective or FDA-approved.

An Invitation to Examine the Evidence — Together
“What’s In Your Vial?” is more than a campaign title. It is an invitation to ask sharper questions, demand clarity and make scientific transparency part of every regenerative medicine conversation. Genesis aims to make its available documentation accessible while encouraging physicians and patients to examine the underlying evidence for themselves.

The “What’s in your vial?” series also invites clinicians to a nationwide educational Zoom discussion, “Merging Two Worlds: Product Creation & Testing Meets Clinical Decision-Making,” on November 18, 2026, at 8 p.m. Eastern, featuring Prof. Dr. Bankole A. Johnson and Holly Hewitt. Register Now

Explore laboratory testing resources and patient education at the links below.

About Genesis Regenerative
Genesis Regenerative focuses on acellular, non-DNA regenerative protein products, including Regenerative Protein Array^® (RPA^®). Its educational initiatives emphasize product characterization, independent laboratory testing, transparency and resources for clinicians and patients. Genesis does not practice medicine or prescribe clinical protocols; treatment decisions remain with qualified healthcare professionals.

https://genesisregenerative.com/clinician-resources/lab-testing/
https://genesisregenerative.com/smart-regen-med-consumer/

Registration Link
https://us02web.zoom.us/meeting/register/mCm11xAJR4W1u4QxDfKfqg#/registration

Joseph Hunt, CCO
Genesis Regenerative
+1 855-320-7559
Visit us on social media:
LinkedIn
Instagram
Facebook